化合物DBPR108 T15079
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
100 mg | 1186426-66-3 | ¥6,360.00 | 询底价 |
5 mg | 1186426-66-3 | ¥1,190.00 | 询底价 |
50 mg | 1186426-66-3 | ¥4,720.00 | 询底价 |
1 mg | 1186426-66-3 | ¥477.00 | 询底价 |
2 mg | 1186426-66-3 | ¥687.00 | 询底价 |
25 mg | 1186426-66-3 | ¥3,330.00 | 询底价 |
1 mL | 1186426-66-3 | ¥1,300.00 | 询底价 |
10 mg | 1186426-66-3 | ¥1,930.00 | 询底价 |
Product Introduction
Bioactivity
英文名: DBPR108
描述: DBPR108是新型、具有口服活性、选择性的DPP4抑制剂,IC50=为15nM,对DPP8和DPP9基本无抑制。
体外活性: DBPR108 displays a more than 3000-fold selectivity over DPP8 DPP9, FAP and DPP-II.
体内活性: DBPR108 is a potent, selective, long-acting and safe DPP-IV inhibitor as a potential treatment of type 2 diabetes mellitus. The in vivo effects of DBPR108, including inhibition of plasma DPP-IV activity and suppression of blood glucose elevation, were also demonstrated.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : ≥ 25 mg/mL (77.07 mM)
关键字: Inhibitor | DBPR-108 | inhibit | DPP | DBPR 108 | Dipeptidyl Peptidase | DBPR108
相关产品: RA190 | Proteasome-IN-5 | AC-55541 | Alogliptin Benzoate | VR23 | Calpeptin | Ixazomib | UK-101 | UAMC00039 dihydrochloride | Aprotinin
相关库: Drug Repurposing Compound Library | HIF-1 Signaling Pathway Compound Library | ReFRAME Related Library | Clinical Compound Library | Bioactive Compounds Library Max | Ubiquitination Compound Library | Inhibitor Library | Anti-Diabetic Compound Library | Metabolism Compound Library | Orally Active Compound Library
化合物DBPR108 T15079信息由TargetMol中国为您提供,如您想了解更多关于化合物DBPR108 T15079报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途